Lv4
570 积分 2025-11-17 加入
Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non–small cell lung cancer
2天前
已完结
Cancer-associated cachexia
6天前
已完结
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
6天前
已完结
Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non‐small cell lung cancer
22天前
已完结
Beyond the third lumbar vertebra (L3): Thoracic computed tomography-derived muscle mass and quality assessment as a practical alternative for body composition analysis
22天前
已完结
Lung Cancer 2020
1个月前
已完结
Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non–Small Cell Lung Cancer
1个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non‐small cell lung cancer
1个月前
已完结
Redefining outcomes in asthma—remission and beyond
1个月前
已关闭
皖公网安备34019202002308
